File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Introductory remarks: Why 5-hydroxytryptamine?

TitleIntroductory remarks: Why 5-hydroxytryptamine?
Authors
Vanhoutte, PM
Issue Date1983
Citation
Federation Proceedings, 1983, v. 42 n. 2, p. 211-212 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/170690
ISSN
0014-9446
ISI Accession Number ID
WOS:A1983QB76100014

 

DC FieldValueLanguage
dc.contributor.authorVanhoutte, PMen_US
dc.date.accessioned2012-10-30T06:10:28Z-
dc.date.available2012-10-30T06:10:28Z-
dc.date.issued1983en_US
dc.identifier.citationFederation Proceedings, 1983, v. 42 n. 2, p. 211-212en_US
dc.identifier.issn0014-9446en_US
dc.identifier.urihttp://hdl.handle.net/10722/170690-
dc.languageengen_US
dc.relation.ispartofFederation Proceedingsen_US
dc.subject.meshAnimalsen_US
dc.subject.meshHumansen_US
dc.subject.meshModels, Biologicalen_US
dc.subject.meshPlatelet Aggregationen_US
dc.subject.meshSerotonin - Physiologyen_US
dc.subject.meshVasoconstrictionen_US
dc.titleIntroductory remarks: Why 5-hydroxytryptamine?en_US
dc.typeArticleen_US
dc.identifier.emailVanHoutte, PM:vanhoutt@hku.hken_US
dc.identifier.authorityVanHoutte, PM=rp00238en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.pmid6822292-
dc.identifier.scopuseid_2-s2.0-0020550739en_US
dc.identifier.volume42en_US
dc.identifier.issue2en_US
dc.identifier.spage211en_US
dc.identifier.epage212en_US
dc.identifier.isiWOS:A1983QB76100014-
dc.identifier.scopusauthoridVanHoutte, PM=7202304247en_US
dc.identifier.issnl0014-9446-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats